Yates Clayton Clopton bought GNVR
April 15, 2026 · Form 4 insider transaction
Yates Clayton Clopton bought 200,000 shares of Genvor Incorporated at $0.50 per share, a transaction worth $100.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 202 days after the transaction.
Footnotes
Shares issued upon Dr. Yates' conversion of $100,000 in outstanding payables owed by the Company to Dr. Yates, pursuant to his scientific advisor agreement with the Company and the Company's restructured compensation package previously approved by the Company, which permits Dr. Yates to convert amounts due to him into Company common stock.; Dr. Yates has voting and dispositive power with respect to shares held in the name of ACT Holdings, LLC, and is therefore deemed to be beneficial owner of shares held in its name.